Remote screening of diabetic retinopathy can help in early detection, even before there are any noticeable vision changes
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Rising demands and advancements in eye care drive growth
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
Yesafili, received marketing authorization approval from the European Commission for the European Union
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Subscribe To Our Newsletter & Stay Updated
